Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

6 Giant Investing Trends for 2020 That You Don’t Want to Miss

By InvestorPlace Staff
These investing trends for 2020 cover trends that will disrupt everything from the housing market to the cars we drive. Don't miss out.

Ignore the Canopy Growth Ambulance Chasers

By Will Ashworth, InvestorPlace Contributor
On Nov. 21, Canopy Growth responded to the potential class-action suits. CGC stock fell on the news. Should shareholders be concerned?

Aphria Stock May Be Headed Higher, But It’s Too Soon to Tell

By Will Ashworth, InvestorPlace Contributor
Canadian cannabis producer Aphria hit an all-time low of $3.76 Nov. 19. Since then, Aphria stock has recovered nicely. Is that the bottom?

Should Investors Buy or Sell Canopy Stock Going Into 2020?

By Ian Bezek, InvestorPlace Contributor
Investors dumped CGC stock following its most recent earnings report. But Canopy Growth stock is starting to bounce back now.

Canopy Growth Stock Sparks Plenty of Dead-Cat Debate After a Recent Rally

By Todd Shriber, InvestorPlace Contributor
Cannabis stocks are going through some drama, but when the smoke clears, Canopy Growth stock could be seen as a winner.

5 Things Aurora Cannabis Must Do to Get ACB Stock Back on Track

By Wayne Duggan, InvestorPlace Contributor
Things have gone from bad to worse for ACB stock investors in the past month. Management needs to get serious about making some aggressive changes to get Aurora stock back on track.

The More You Look, the Less Compelling Aurora Stock Seems

By Faisal Humayun, InvestorPlace Contributor
Cash burn will result in further equity dilution. Medicinal cannabis growth is likely to be slow with little evidence-backed research.

Cronos Stock Gets Closer to Being a Buy, but It’s Not There Yet

By Vince Martin, InvestorPlace Contributor
Cronos stock long has been the pot stock for investors who don't like pot stocks. That might be enough for a buy at some point.

Aurora Cannabis Stock Faces a Cold Winter, Rapid Cash Burn

By Dana Blankenhorn, InvestorPlace Contributor
Cash is now king in the marijuana market, and Aurora Cannabis is among those cutting back. Aurora stock depends on U.S. legalization.

7 Unsteady Stocks Investors Should Consider Selling Before 2020

By Will Healy, InvestorPlace Contributor
These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.

Near-Term Pain Will Bring Aurora Cannabis Stock Long-Term Gains

By Luke Lango, InvestorPlace Senior Investment Analyst
The market is having trouble seeing the forest through the trees on ACB stock. So long as this remains true, shares won't rebound.

Cannabis Stocks: The Latest Bump Is Only the Beginning

By InvestorPlace Research Staff
If you are bold enough to act now, there is potential for life-changing profits in cannabis stocks.

Investors Should Stop Calling Tilray Stock a Top-Tier Marijuana Name

By Will Healy, InvestorPlace Contributor
Hope for U.S. legalization helped Tilray stock, but financial conditions indicate it may struggle to remain top-tier or perhaps, survive.

The Long-Term Cannabis Story Makes Aurora Stock a Strong Buy

By Ian Cooper, InvestorPlace Contributor
With the MORE Act, higher U.S. approval and presidential candidates commenting, there’s plenty of growth for Aurora stock.

Consider Adding New Positions in U.S. Cannabis Stocks

By InvestorPlace Staff
It's no secret Matt McCall is searching for emerging trends. This week, he discusses cannabis stocks and a breakthrough biotech therapy.

3 Reasons Why the Bottom Could Be in for Canopy Growth Stock

By Josh Enomoto, InvestorPlace Contributor
But with marijuana stocks spilling so much red ink in the green market, does CGC stock provide an opportunity for contrarians?

Don’t Buy Cronos Stock on the U.S. House Committee Vote

By Will Healy, InvestorPlace Contributor
CRON stock should become an eventual winner for investors, but the rally sparked by the vote in the U.S. House will likely not last.

The Smart Money Is Waiting for Cannabis Stocks to Stabilize

By David Moadel, InvestorPlace Contributor
It makes sense to stay on the sidelines while cannabis stocks deal with supply issues. Waiting for stability is the best play right now.

Aurora Stock Pops on Hope of Federal Marijuana Legalization

By Brad Moon, InvestorPlace Contributor
ACB stock rallied with a bill that would decriminalize marijuana at the federal level up for a vote. Analysts are upbeat on Aurora stock.
Load More